 |
|
| Blog results | Results 1 - 10 of about 3,039 for philadelphia chromosome leukemia. (0.20 seconds) |
| Sorted by relevance Sort by date |
| 8 Dec 2009 by pillscribe Nilotinib (Tasigna) showed superior efficacy over Glivec (imatinib) in the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase, according to a Novartis ... DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/ - References |
| 5 hours ago by Ani ... drug called imatinib mesylate along with regular chemotherapy can almost double the survival rate of children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). ... Health News - http://blog.taragana.com/health/ |
| 8 Dec 2009 by scinews@sciencenews.org (Science News) All three drugs disable a rogue enzyme called BCR-ABL that removes the brakes on leukemia cells' growth (SN: 1/1/05, p. 14). A genetic mutation, called Philadelphia chromosome, results in the production of this abnormal enzyme, ... Latest Science News Features, Blog Entries,... - http://www.sciencenews.org/view/feature/id/41220... - References |
| 4 Nov 2009 by admin Get information about chronic myelogenous leukemia, allogeneic stem cell transplant, acute myelogenous leukemia, philadelphia chromosome, causes of acute myelogenous leukemia at Just Cancer. Just Cancer - http://www.justcancer.org/ |
| 3 Dec 2009 by r "Here's how it happened: Working in Chicago in the 1970's, Janet Rowley discovered that the “Philadelphia Chromosome,” an abnormal chromosome seen only in the leukemia cells of patients with CML." When Bad Things Happen To Famous People ... purple medical blog - http://purplemedicalblog.blogspot.com/ - References |
| 12 Dec 2009 In a large Phase III clinical trial, Tasigna® (nilotinib) demonstrated greater efficacy over Glivec® (imatinib) in the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) ... Pharmainfo.net - http://www.pharmainfo.net/ |
| 25 Jan 2008 by Brave, M., Goodman, V., Kaminskas, E.,... ... accelerated phase, or myeloid or lymphoid blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy including imatinib. ... Clinical Cancer Research recent issues - http://clincancerres.aacrjournals.org/ - References [ More results from Clinical Cancer Research recent issues ] |
| 8 Dec 2009 by Maureen Martino Novartis intends to file worldwide applications for Tasigna for newly-diagnosed patients with Philadelphia chromosome-positive CML in chronic phase. "Considering the already low rates of progression to advanced disease and the excellent ... News - http://www.fiercepharma.com/news |
| 30 Nov 2009 ... drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). ... BioSpace.com Featured News and Stories - http://www.biospace.com/ [ More results from BioSpace.com Featured News and Stories ] |
| 5 Dec 2009 by BJS Blaine W. Robinson, Ph.D., a research scientist at The Children's Hospital of Philadelphia, will present research findings in infant ALL at the annual meeting of the American Society of Hematology on Dec. 8. ... For the majority of these high-risk infants, the problem is within the structure of a specific chromosome. In an abnormality called the MLL translocation, the MLL gene on chromosome 11 breaks and joins with any one of many different "partner" genes from other ... Science Blog - Science news straight from... - http://www.scienceblog.com/cms/frontpage1 - References |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
